BSC-3301

N/A

Report date: 2024/04/01 14:18:52
NME

Base Information

Drug NameBSC-3301
Drug Alias NameBSC-3301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-interacting serine/threonine-protein kinase 1 inhibitors
TargetsReceptor-interacting serine/threonine-protein kinase 1
Therapy Area/IndicationsWet age-related macular degenerationAmyotrophic Lateral SclerosisAlzheimer Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiSiChem Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiSiChem Co Ltd
Inactive CompaniesN/A
Active IndicationsWet age-related macular degenerationAmyotrophic Lateral SclerosisAlzheimer Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A